International Conference on Medical and Pharmaceutical Science

  02 May 2025 - 03 May 2025

   San Antonio, Texas

conference-img

International Conference on Medical and Pharmaceutical Science

02 May 2025

 - 

03 May 2025

San Antonio, Texas



The International Conference on Medical and Pharmaceutical Science brings together global researchers, healthcare professionals, and industry experts to discuss the latest innovations, research findings, and clinical practices.

The conference will feature keynote speeches from renowned medical and pharmaceutical experts, in-depth research paper presentations, and interactive panel discussions. Attendees will have the opportunity to engage in professional networking sessions and explore an exhibition showcasing the latest technologies and innovations in the medical and pharmaceutical fields.

3rd Edition of Global Meeting on Cancer Research and Therapy (GMCRT-2026)

On: 09 Jul 2026

-

10 Jul 2026


Annual International Congress on the Future of Breast Cancer East

On: 10 Jul 2026

-

11 Jul 2026


ISMB 2026 (Intelligent Systems for Molecular Biology)

On: 12 Jul 2026

-

16 Jul 2026


Future NRG Oncology Meeting

On: 16 Jul 2026

-

18 Jul 2026


Genito-Urinary Oncology Summit 2026

On: 16 Jul 2026

-

18 Jul 2026


3rd Edition of Global Meeting on Cancer Research and Therapy (GMCRT-2026)

On: 09 Jul 2026

-

10 Jul 2026


Annual International Congress on the Future of Breast Cancer East

On: 10 Jul 2026

-

11 Jul 2026


ISMB 2026 (Intelligent Systems for Molecular Biology)

On: 12 Jul 2026

-

16 Jul 2026


Future NRG Oncology Meeting

On: 16 Jul 2026

-

18 Jul 2026


Genito-Urinary Oncology Summit 2026

On: 16 Jul 2026

-

18 Jul 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

2.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers

3.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

4.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

5.

WHO launches plan for free child cancer medicines

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot